A Glasgow-headquartered online pharmacy which specialises in offering medications direct to patients in regulated digital clinic has appointed a chief growth officer as the firm continues to expand.
Tushar Kaul joins the company, one of the fastest-growing in Scotland, as demand for prescription drugs used to treat obesity and type 2 diabetes, such as Ozempic, Wegovy and Mounajro, supplied by private providers continues to rise.
Over 300,000 Scots, and around 2 million people UK-wide are now accessing the so-called ‘GLP-1’ treatments from regulated private providers, estimated to be 5-6 times as many as from the NHS, according to the company’s own data.
Kaul joins Simple Online from Agrolimen, the €2 billion-valued consumer corporation behind some of Europe’s fastest-growing digital and direct-to-consumer nutrition brands.
As direct-to-consumer Managing Director of Agrolimen’s Nature Menu brand, Kaul spearheaded growth, and also brings scaleup experience from Campbell’s Prime Meat and Bella & Duke.
Addy Mohammed, CEO and Co-founder of Simple Online Healthcare, said: “Tushar joins at a pivotal moment for the business, as we accelerate our international growth strategy and continue strengthening our leadership team. His experience scaling direct-to-consumer, mission-driven organisations will be invaluable as we continue to expand responsibly and safely in a sector experiencing rapid change.”
“We are committed”, continued Mohammed, “to raising standards in an emerging global health category. That means doubling down on regulation, education, and safe clinical pathways while tackling the growth of unlicensed suppliers and the black market.”
Tushar Kaul, Chief Growth Officer, Simple Online Healthcare, said: “What drew me to Simple was its mission – and the people who live it every day. This is a team that cares deeply about patient outcomes and responsible innovation. I’m honoured to join them and contribute to the next stage of growth, helping us scale in a way that stays true to our values and delivers meaningful impact at global scale.”
In June, Simple Online announced it was launching in Denmark, its third international market, while more than tripling revenue to £66 million in the last financial year. The company expects to more than double revenue in the current financial year.
Addy Mohammed added: “As we expand internationally, we’re also accelerating investment in technology, product and innovation talent. With AI now woven into our clinical and patient experience journeys, we’re building a next-generation healthcare platform that scales responsibly while keeping quality and patient safety at its core.”
In September, Simple Online Healthcare was identified as one of only three Scotland-headquartered businesses in Tech Nation’s ‘Future Fifty 2025’. Also in September, the company was included in CodeBase’s ‘Techscaler Ones to Watch’ list of tech startups and scaleups in Scotland.
